Lee, D.-H.; Jeong, Y.-J.; Won, J.-Y.; Sim, H.-I.; Park, Y.; Jin, H.-S.
PBK/TOPK Is a Favorable Prognostic Biomarker Correlated with Antitumor Immunity in Colon Cancers. Biomedicines 2022, 10, 299.
https://doi.org/10.3390/biomedicines10020299
AMA Style
Lee D-H, Jeong Y-J, Won J-Y, Sim H-I, Park Y, Jin H-S.
PBK/TOPK Is a Favorable Prognostic Biomarker Correlated with Antitumor Immunity in Colon Cancers. Biomedicines. 2022; 10(2):299.
https://doi.org/10.3390/biomedicines10020299
Chicago/Turabian Style
Lee, Dong-Hee, Yu-Jeong Jeong, Ju-Young Won, Hye-In Sim, Yoon Park, and Hyung-Seung Jin.
2022. "PBK/TOPK Is a Favorable Prognostic Biomarker Correlated with Antitumor Immunity in Colon Cancers" Biomedicines 10, no. 2: 299.
https://doi.org/10.3390/biomedicines10020299
APA Style
Lee, D. -H., Jeong, Y. -J., Won, J. -Y., Sim, H. -I., Park, Y., & Jin, H. -S.
(2022). PBK/TOPK Is a Favorable Prognostic Biomarker Correlated with Antitumor Immunity in Colon Cancers. Biomedicines, 10(2), 299.
https://doi.org/10.3390/biomedicines10020299